William K. Heiden

2012

In 2012, William K. Heiden earned a total compensation of $3.9M as President and Chief Executive Officer at AMAG Pharmaceuticals.

Compensation breakdown

Bonus$75,000
Non-Equity Incentive Plan$259,875
Option Awards$1,892,430
Salary$307,692
Stock Awards$1,299,000
Other$22,826
Total$3,856,823

Heiden received $1.9M in option awards, accounting for 49% of the total pay in 2012.

Heiden also received $75K in bonus, $259.9K in non-equity incentive plan, $307.7K in salary, $1.3M in stock awards and $22.8K in other compensation.

Rankings

In 2012, William K. Heiden's compensation ranked 1,724th out of 11,487 executives tracked by ExecPay. In other words, Heiden earned more than 85.0% of executives.

ClassificationRankingPercentile
All
1,724
out of 11,487
85th
Division
Manufacturing
618
out of 4,253
86th
Major group
Chemicals And Allied Products
141
out of 1,198
88th
Industry group
Drugs
77
out of 920
92nd
Industry
Pharmaceutical Preparations
65
out of 700
91st
Source: SEC filing on April 16, 2015.

Heiden's colleagues

We found five more compensation records of executives who worked with William K. Heiden at AMAG Pharmaceuticals in 2012.

2012

Frank Thomas

AMAG Pharmaceuticals

Chief Operating Officer

2012

Lee Allen

AMAG Pharmaceuticals

Chief Medical Officer

2012

Christopher White

AMAG Pharmaceuticals

Senior Vice President and Chief Business Officer

2012

Scott Townsend

AMAG Pharmaceuticals

General Counsel

2012

Scott Holmes

AMAG Pharmaceuticals

Chief Accounting Officer

News

You may also like